SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001096906-23-001188
Filing Date
2023-05-25
Accepted
2023-05-25 16:04:19
Documents
14
Period of Report
2023-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING axim-20230523.htm   iXBRL 8-K 19429
2 CONSULTING AGREEMENT EFFECTIVE MAY 23, 2023, BY AND BETWEEN THE COMPANY AND ACCA axim_ex10z1.htm EX-10.1 38217
  Complete submission text file 0001096906-23-001188.txt   200384

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20230523_def.xml EX-101.DEF 1842
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20230523_lab.xml EX-101.LAB 20742
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20230523_pre.xml EX-101.PRE 13772
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20230523.xsd EX-101.SCH 2378
8 EXTRACTED XBRL INSTANCE DOCUMENT axim-20230523_htm.xml XML 2442
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 23960394
SIC: 2834 Pharmaceutical Preparations